history of glp-1 agonists glucagon-like peptide-1 receptor Frontiers | GLP-1 receptor agonists:

The GLP-1 receptor assay is a powerful tool for the identification of GLP-1 receptor agonists aimed at treating obesity and type 2 diabetes

Over 30 years ago scientists discovered the potential of Gila monster venom as a treatment for type 2 diabetes.

See if you qualify

Starting in July 2026, some people with Medicare will be eligible for Medicare coverage of certain weight-loss medications through the new Medicare GLP1 Bridge Program

Although most of the studies reported an association between GLP-1 RA and increased residual gastric contents, evidence linking these medications to a statistically significant rise in regurgitation or aspiration events remains highly inconsistent